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P lant genomics is a fast moving field with applications ranging from crop improvement and protection, 
to production of compounds of pharma­
ceutical interest as well as bioremediation 
of contaminated soil. Moreover, with 
market pressure increasing on the large 
food crops such as wheat, corn and canola 
for the production of biofuels, the field is 
attracting growing attention globally and 
in many European countries in spite of 
the red tape still in the way of the introduction of GM plants. 
Chiara Tonelli, a plant geneticist at the University of Milan, ex­
plains what lies ahead for research and industry.
You are working on the genomics of 
Arabidopsis, why is this plant so 
important to plant geneticists?
The decoding of Arabidopsis 
thaliana’s genome has been 
the equivalent of the Human 
genome project. In a word it’s 
the mouse of plant genetics, as 
it’s a wonderful model organ­
ism for many crop plants 
as it’s small, easy and fast 
to grow as it has a life 
cycle, from seed to seed, of 
three months. Many of the 
more sophisticated in­
novations, which we 
will see in the next 
generations of trans­
genic crops, have been 
discovered in this plant. 
Today there is great deal of 
potential innovation in this field 
but launch on the market is very slow 
as industry focuses on large crops such as corn 
and soy and changes in regulations are very slow.
Plant genetics is commonly associated with the production of 
GMOs, still widely opposed by consumers in Europe. What are 
actually their applications in traditional plant breeding?
Genetic engineering is just a technology use to insert genes into 
plants, but what is really valuable is to understand the role of 
genes and which are responsible for traits such as resistance to 
pathogens, tolerance to low or high temperatures, high salinity 
in the soil, drought, in order to select plants capable to grow and 
produce in adverse conditions or in marginal lands. Our lab has 
two main lines of research, one is studying the regulation of an­
thocyanins, the red/blue pigments which give plants protection 
against environmental stresses and disease. This pigment could 
be used as natural food colourants to replace many artificial 
colours used in various foods. This improved understanding 
of the genetics of anthocyanins also provides a better platform 
for studying their antioxidant properties, important in the fight 
against cancer, cardiovascular disease and age­related degen­
eration We have already produced a line of corn with a high 
concentration of anthocyanins. The second line of research is 
on genes conferring tolerance to environmental stress such a 
drought or salinity. We have identified a gene that controls the 
rate of water consumption in Arabidopsis domain and we have 
been able to cut up to 30% of water consumption through the 
inactivation of this gene. This innovation is potentially applica­
ble in soybean, rice, corn and cotton. Transgenic technologies, 
involving the insertion of genes from other species into plant 
DNA is not the only way to use genetic information. Today we 
are looking at cisgenesis, namely the modification of the endog­
enous plant genes, or the insertion of genes from other plants. 
This approach raises less concern in the public opinion. 
Is it possible to envisage non GM biotech crops for Europe, es-
pecially for valuable but minor food crops such as toma-
tos, zucchini and other vegetables typical 
of the Mediterranean? 
Yes and it would be a great 
advantage as for typi­
cal products that are 
experiencing grow­
ing difficulties due 
to viruses and other 
pathogens. An exam­
ple is the San Mar­
zano tomato 
developed in 
S o u t h e r n 
Italy by 
A g r o b i o s 
Metapontum 
but never cul­
tivated because of 
GM­free regulations. 
To make a comparison 
with the pharmaceutical indus­
tries where orphan drugs have a dedi­
cated approval protocol, I believe we should have a 
regulation for minor crops not relevant to major industries.
Even after 15 years on the market GM crops are still not com-
pletely accepted by consumers, what do you think could make 
them more appealing?
In spite of the research completed there have actually been few 
GM products on the market and we have still not seen much 
from the latest and more sophisticated research. I believe more 
innovative products should make it to the market with charac­
teristics appealing to consumers as, for instance, higher vitamin 
content and pathogen resistance. An example, though poorly 
conveyed to the general public is Bt corn, which has a lower level 
of fumonisin, a cancer inducing toxin.
Among the cultivated species, the grape is unusual in that it has never undergone any biologi­
cal modification, except those resulting 
from traditional cross breeding. 
Biologist and entrepreneur Claudio 
Quarta discusses how biotech may im­
prove, and actually 
save the wine indus­
try and market from 
the consequences of 
global warming in the coming years.
What kind of innovation can molecular 
biotechnologies bring to wine-making? 
When we talk about molecular bio­
technologies in relation to wine and 
grapevine we refer to the genome and, 
consequently, to proteome and me­
tabolome studies. The completion of 
the grapevine genome map enables us 
to improve our knowledge of various 
species and their evolution. It is also 
a useful tool for product traceabil­
ity, which represents an increasingly 
urgent need. On the other hand the 
application of proteomics and metabo­
lomics, will allow the evaluation of dif­
ferences in various synthetic processes 
in the plant, allowing selection of the 
most favourable ones. These technologies 
are already applied in some Italian and for­
eign labs, especially in relation to secondary 
metabolites such as polyphenols, carotens and 
aromatic substances. These methodologies will also 
provide us with a better understanding of the role of en­
vironmental factors in determining grape features. This 
should enable us to select natural mutants with particular 
metabolic synthetic pathways. These studies may also allow 
us to predict the influence of the changing climate and to 
better select environments adapted to the cultivation of the 
grapevine. We will therefore be able to “protect” our most 
prestigious species from climate change related risks. 
 
What are the benefits of molecular technologies in the 
winemaking process? 
The wide­spread application of non­traditional quality 
sensors inaugurated a new era in the innovation of the 
winemaking process. 
They are used both in the control of the 
winemaking process and also in check­
ing the grape maturity. Instead of 
applying difficult analytical methods, 
requiring a long time and complicated 
tools, one will be able to evaluate the 
quality and quantity levels of different 
secondary metabolites which are crucial for 
the characteristics of wine. These include antocians, tannins, 
terpens and non­isoprenoids which are produced during the 
maturation process, and can be quantified with an ELISA assay. 
The aim is to produce a immunological analysis kit for quick 
and easy dosage of different metabolites before and during the 
winemaking process. 
Are these technologies already applied abroad and what im-
pact can they have on the wine market? 
As far as I know, these techniques are still 
not available for practical use, not even 
abroad, although research has reached an 
advanced stage in countries such as Aus­
tralia and France. In Italy, at the moment, 
the only research group engaged in the 
development of biosensors for the evalu­
ation of antocian and tannin expression 
in red grapes is Vegetable Production 
Department of the University of Milan 
– DIPROVE, in collaboration with the 
biotechnology firm Areta Internation­
al and my own company Magistravini. 
We are working within the Insubria 
Biopark. These new techniques will 
provide many small companies with 
analytical results which are crucial 
for the improvement of wine quality 
and which will allow bigger cellars, 
such as the “social” ones, which can 
rapidly and effectively monitor grape 
stocks to be used in the production of 
different wines according to their pheno­
lic quality.
 
Can we foresee a non-GMO food biotech in 
Europe, particularly in the Mediterranean re-
gion, which is home to many high-quality crops?  
The Mediterranean region, including Italy, features 
a markedly high genetic variation within its vegetable 
and fruit range. Species selection, characterization and 
conservation through molecular genetics are therefore a 
priority. This should allow the identification of genes are 
involved in various synthesis processes, the dosage of their 
products and the identification the metabolic pathways of 
neutraceutic products. 
We will then be able to improve Mediterranean species 
on the basis of the qualitiy of their substances and of their 
conservation properties and suitability to industrial trans­
formation. The identification of disease resistance genes is 
equally important in order to create strong varieties and 
reduce the use of chemicals in agriculture. In con­
clusion, I believe that Molecular Marker As­
sisted Genetic Improvement techniques 
are the first step towards traditional 
genetic improvement programmes 
involving crossbreeding. 
The aim of this process is that of cre­
ating new varieties which will be more 
suitable to the needs of the modern market and 
are resistant to diseases, maximizing the desired results and 
reducing testing times and costs. 
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